Nageatte Ibrahim practices Oncology. She studied medicine at Eastern Virginia Medical School. Nageatte Ibrahim is also published. She has 12 publications published. The lastest publication: "Phase I study of the MEK inhibitor trametinib in combination with the AKT inhibitor afuresertib in patients with solid tumors and multiple myeloma.'
![]() |
Dr. Ramesh A. Shivdasani, MD
![]() ![]() |
![]() |
Dr. Neeharika Srivastava, MD
![]() |
![]() |
Dr. Panagiotis Konstantinopoulos, MD
![]() ![]() |
![]() |
Dr. Andrea C. Phelps, MD
![]() ![]() |
![]() |
Dr. Leroy M. Parker, MD
![]() |
![]() |
Dr. Alexi A. Wright, MD
![]() ![]() |
![]() |
Dr. Jeffrey M. Peppercorn, MD
![]() ![]() |
![]() |
Dr. Frank S. Hodi Jr., MD
![]() ![]() |
![]() |
Dr. Nadine M. Tung, MD
![]() |
![]() |
Dr. John R. Clark, MD
![]() |
![]() |
Dr. Wasif M. Saif, MD
![]() |